Palo Alto Investors LP

PALO ALTO, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$672.2M2026 Q3
Positions56
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.59.9%

Palo Alto Investors LP reported 56 positions worth $672.2M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: PTCT (8.4%).

10 / 56 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 PTCTPTC Therapeutics$56.7M8.44%875,349——-5.9%
▸ 2 IOVAIovance Biotherapeutics$51.4M7.65%3,471,456——-49.1%
▸ 3 INSMInsmed$50.6M7.53%443,645——+7.7%
▸ 4 ACADAcadia Pharmaceuticals$50.1M7.45%2,485,608——-6.9%
▸ 5 BMRNBiomarin Pharmaceutical$38.5M5.74%642,455——-3.3%
▸ 6 MIRMMirum Pharmaceuticals$33.1M4.93%387,314——+7.1%
▸ 7 UTHRUnited Therapeutics$31.9M4.75%58,875——+8.5%
▸ 8 DYNDyne Therapeutics$30.3M4.51%1,881,927——+6.5%
▸ 9 BIIBBiogen$30.0M4.47%132,918——+11.4%
▸ 10 ANABAnaptysbio$29.9M4.45%595,264——-8.0%

Pro Feature

The remaining 46 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Palo Alto Investors LP hold as of Q3 2026?

Palo Alto Investors LP reported 56 positions worth $672.2M in its Q3 2026 13F filing. Largest positions: PTCT (8.4%), IOVA (7.7%), INSM (7.5%), ACAD (7.5%) and BMRN (5.7%).

What did Palo Alto Investors LP buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Palo Alto Investors LP sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.